A detailed history of Valmark Advisers, Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Valmark Advisers, Inc. holds 6,904 shares of TMDX stock, worth $462,222. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,904
Previous 6,803 1.48%
Holding current value
$462,222
Previous $1.07 Million 59.74%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

BUY
$59.28 - $144.9 $5,987 - $14,634
101 Added 1.48%
6,904 $430,000
Q3 2024

Oct 25, 2024

SELL
$135.68 - $176.11 $7,055 - $9,157
-52 Reduced 0.76%
6,803 $1.07 Million
Q2 2024

Jul 31, 2024

SELL
$72.62 - $150.62 $12,998 - $26,960
-179 Reduced 2.54%
6,855 $1.03 Million
Q1 2024

May 03, 2024

SELL
$70.86 - $89.93 $18,848 - $23,921
-266 Reduced 3.64%
7,034 $520,000
Q4 2023

Feb 02, 2024

BUY
$36.74 - $81.08 $268,202 - $591,884
7,300 New
7,300 $576,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.13B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Valmark Advisers, Inc. Portfolio

Follow Valmark Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valmark Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Valmark Advisers, Inc. with notifications on news.